There are 122 resources available
Updates and Implications of Consensus Molecular Subtyping
Presenter: Scott Kopetz, United States
Session: Session VIII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Webcast
Is Immunophenotyping Becoming A Reality?
Presenter: Franck Pagès, France
Session: Session VIII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Webcast
O-11: Monitoring molecular residual disease by circulating tumor DNA in resectable colorectal cancer: Molecular subgroup analyses of a prospective observational study GALAXY in CIRCULATE-Japan
Presenter: Hiromichi Shirasu, Japan
Session: Session VIII: Colorectal Cancer: Metastatic Disease
Resources:
Webcast
Are We Making Progress With the Use/Implementation of Liquid Biopsies in GI Cancer
Presenter: Jonathan Loree, Canada
Session: Session VIII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Webcast
SO-29: Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion-positive gastrointestinal (GI) cancer: an expanded dataset
Presenter: Valentina Boni, Spain
Session: Session VIII: Colorectal Cancer: Metastatic Disease
Resources:
Webcast
Rare Genomic Alterations Including Mutations and Fusions; PD-1
Presenter: Michael Overman, United States
Session: Session VIII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Webcast
Q&A
Presenter: Fortunato Ciardiello, Italy
Session: Session VIII: Colorectal Cancer: Metastatic Disease
Resources:
Webcast
Neoadjuvant Therapy for Rectal Cancer: Less or More Chemotherapy and/or Radiotherapy – When and How? Lessons From Recent Studies
Presenter: Michel Ducreux, France
Session: Session IX: Colon and Rectal Cancer: Early Disease
Resources:
Webcast
O-12: Phase II Study of Preoperative (Preop) Chemoradiotherapy (CTTRT) Plus Avelumab (AVE) In Patients (PTS) With Locally Advanced Rectal Cancer (LARC): The AVANA Study
Presenter: Lisa Salvatore, Italy
Session: Session IX: Colon and Rectal Cancer: Early Disease
Resources:
Webcast
SO-30: Efficacy and Safety of Neoadjuvant Short-Course Radiation Followed by mFOLFOX-6 plus Avelumab for Locally-Advanced Rectal Adenocarcinoma: Averectal Study
Presenter: Ali Shamseddine, Lebanon
Session: Session IX: Colon and Rectal Cancer: Early Disease
Resources:
Webcast